Tokorozawa, Japan

Tamotsu Kanazawa


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Tokorozawa, JA (1977)
  • Tokorozawa, JP (1981)

Company Filing History:


Years Active: 1977-1981

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Tamotsu Kanazawa of Tokorozawa, Japan

Introduction

Tamotsu Kanazawa is an innovative inventor based in Tokorozawa, Japan, known for his significant contributions to the field of pharmaceuticals. He holds three patents that focus on novel hydroxamic acid compounds with promising applications in medicine. His work has the potential to influence the treatment of various infections and diseases.

Latest Patents

Among his latest inventions are two notable patents: a novel hydroxamic acid compound along with a method for its preparation, and a specific compound represented by the general formula: Bis-(meta-amidinophenoxy)-compounds. These compounds, along with their pharmacologically acceptable acid addition salts, have demonstrated excellent antifungal, antibacterial, and anti-trichomonal activities, showcasing Kanazawa's commitment to advancing therapeutic solutions.

Career Highlights

Tamotsu Kanazawa is currently associated with Eisai Company, Limited, a leading global pharmaceutical company. His role at Eisai emphasizes his dedication to research and development, where he focuses on innovating new therapeutic agents that can significantly impact public health.

Collaborations

Throughout his career, Kanazawa has collaborated with esteemed colleagues, including Sachiyuki Hamano and Shin-ichi Kitamura. These partnerships reflect a strong cooperative effort in the research community, aimed at enhancing the efficacy and safety of new pharmaceutical products.

Conclusion

Tamotsu Kanazawa is an influential figure in the realm of scientific innovation, particularly in pharmaceuticals. His recent patents and collaborations underscore his role in developing effective medical treatments that can greatly improve patient care. As research in this field continues to evolve, Kanazawa’s contributions will likely play a crucial part in the advancement of health solutions worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…